Please login to the form below

Not currently logged in
Email:
Password:

olodaterol

This page shows the latest olodaterol news and features for those working in and with pharma, biotech and healthcare.

Boehringer posts solid first half as business revamp beds in

Boehringer posts solid first half as business revamp beds in

Boehringer has been trying transfer patients from Spiriva to new combination Spiolto (tiotropium/olodaterol), but has reportedly been encountering payer resistance.

Latest news

More from news
Approximately 3 fully matching, plus 23 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....